litlas
ログインアカウント作成

Keith S. Kaye

1995–2025 年に発表

187
論文数
28,792
被引用数
95
h 指数
177
i10 指数

被引用数

Keith S. Kaye の年別被引用数1936 年: 被引用 1 件1986 年: 被引用 2 件1987 年: 被引用 1 件1990 年: 被引用 2 件1991 年: 被引用 1 件1992 年: 被引用 2 件1995 年: 被引用 1 件1996 年: 被引用 2 件1997 年: 被引用 2 件1998 年: 被引用 5 件1999 年: 被引用 1 件2000 年: 被引用 3 件2001 年: 被引用 5 件2002 年: 被引用 7 件2003 年: 被引用 23 件2004 年: 被引用 45 件2005 年: 被引用 84 件2006 年: 被引用 112 件2007 年: 被引用 122 件2008 年: 被引用 126 件2009 年: 被引用 148 件2010 年: 被引用 153 件2011 年: 被引用 137 件2012 年: 被引用 149 件2013 年: 被引用 188 件2014 年: 被引用 206 件2015 年: 被引用 174 件2016 年: 被引用 231 件2017 年: 被引用 217 件2018 年: 被引用 190 件2019 年: 被引用 1,024 件2020 年: 被引用 1,023 件2021 年: 被引用 1,015 件2022 年: 被引用 843 件2023 年: 被引用 705 件2024 年: 被引用 1,281 件2025 年: 被引用 581 件2026 年: 被引用 14 件1937〜1985 年は被引用が無いため表示していません1988〜1989 年は被引用が無いため表示していません1993〜1994 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,521 件、この内訳の 25.3%中国: 引用元論文 848 件、この内訳の 8.5%イタリア: 引用元論文 524 件、この内訳の 5.3%イギリス: 引用元論文 484 件、この内訳の 4.9%スペイン: 引用元論文 412 件、この内訳の 4.1%オーストラリア: 引用元論文 370 件、この内訳の 3.7%カナダ: 引用元論文 322 件、この内訳の 3.2%フランス: 引用元論文 322 件、この内訳の 3.2%ドイツ: 引用元論文 279 件、この内訳の 2.8%インド: 引用元論文 222 件、この内訳の 2.2%スイス: 引用元論文 201 件、この内訳の 2%ギリシャ: 引用元論文 188 件、この内訳の 1.9%
0%25.3%その他 32.9%

機関

分野

  • Biochemistry, Genetics and Molecular Biology44.2%
  • Medicine42.5%
  • Immunology and Microbiology5.7%
  • Health Professions1.8%
  • Environmental Science1.4%
  • Agricultural and Biological Sciences0.9%
  • その他3.5%

トピック

  • Antibiotic Resistance in Bacteria16.6%
  • Antibiotics Pharmacokinetics and Efficacy8.4%
  • Antibiotic Use and Resistance6.5%
  • Bacterial Identification and Susceptibility Testing4.6%
  • Nosocomial Infections in ICU4.5%
  • Antimicrobial Resistance in Staphylococcus4.2%
  • その他55.2%

共著者

全論文

検索で開く
  1. International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)

    著者: Brian T. Tsuji, Jason M. Pogue, Alexandre Prehn Zavascki, Mical Paul, George L. Daikos, Alan Forrest, Daniele Roberto Giacobbe, Claudio Viscoli, Helen Giamarellou, Ilias Karaiskos, Donald Kaye, Johan W. Mouton, Vincent H. Tam, Visanu Thamlikitkul, Richard G. Wunderink, Jian Li, Roger L. Nation, Keith S. Kaye - Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy 2019 被引用: 931

  2. Efficacy and safety of sulbactam–durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii–calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK)

    著者: Keith S. Kaye, Andrew F. Shorr, Richard G. Wunderink, Bin Du, Gabrielle Poirier, Khurram Rana, Alita A. Miller, Drew Lewis, John P. O’Donnell, Lan Chen, Harald H. Reinhart, Subasree Srinivasan, Robin Isaacs, David Altarac - The Lancet Infectious Diseases 2023 被引用: 286

  3. Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study

    著者: Jinnethe Reyes, Lauren Komarow, Liang Chen, Lizhao Ge, Blake Hanson, Eric Cober, Erica Herc, Thamer H. Alenazi, Keith S. Kaye, Julia Garcia‐Diaz, Lanjuan Li, Souha S. Kanj, Zhengyin Liu, Jose M Oñate, Robert A. Salata, Kalisvar Marimuthu, Hainv Gao, Zhiyong Zong, Sandra Valderrama, Yunsong Yu, Paul Anantharajah Tambyah, Gregory Weston, Soraya Salcedo, Lillian M Abbo, Qing Xie, Karen Ordóñez, Minggui Wang, Martín E. Stryjewski, José M. Munita, David L. Paterson, Scott Evans, Carol Hill, Keri Baum, Robert A. Bonomo, Barry N. Kreiswirth, María Virginia Villegas, Robin Patel, César A. Arias, Henry F. Chambers, Vance G. Fowler, Yohei Doi, David van Duin, Michael J. Satlin, Jinnethe Reyes, Lauren Komarow, Liang Chen, Lizhao Ge, Blake Hanson, Eric Cober, Erica Herc, Thamer H. Alenazi, Keith S. Kaye, Julia Garcia‐Diaz, Lanjuan Li, Souha S. Kanj, Zhengyin Liu, Jose M Oñate, Robert A. Salata, Kalisvar Marimuthu, Hainv Gao, Zhiyong Zong, Sandra Valderrama, Yunsong Yu, Paul Anantharajah Tambyah, Gregory Weston, Soraya Salcedo, Lillian M Abbo, Qing Xie, Karen Ordóñez, Minggui Wang, Martín E. Stryjewski, José M. Munita, David L. Paterson, Scott Evans, Carol Hill, Keri Baum, Robert A. Bonomo, Barry N. Kreiswirth, María Virginia Villegas, Robin Patel, César A. Arias, Henry F. Chambers, Vance G. Fowler, Yohei Doi, David van Duin, Michael J. Satlin - The Lancet Microbe 2023 被引用: 291

  4. Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial

    著者: Richard G. Wunderink, Yuko Matsunaga, Mari Ariyasu, Philippe Clevenbergh, Roger Echols, Keith S. Kaye, Marin H. Kollef, Anju Menon, Jason M. Pogue, Andrew F. Shorr, Jean‐François Timsit, Markus Zeitlinger, Tsutae Den Nagata - The Lancet Infectious Diseases 2020 被引用: 464

  5. Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study

    著者: Minggui Wang, Michelle Earley, Liang Chen, Blake Hanson, Yunsong Yu, Zhengyin Liu, Soraya Salcedo, Eric Cober, Lanjuan Li, Souha S. Kanj, Hainv Gao, José M. Munita, Karen Ordóñez, Greg Weston, Michael J. Satlin, Sandra Valderrama, Kalisvar Marimuthu, Martín E. Stryjewski, Lauren Komarow, Courtney Luterbach, Steve H. Marshall, Susan D. Rudin, Claudia Manca, David L. Paterson, Jinnethe Reyes, María Virginia Villegas, Scott Evans, Carol Hill, Rebekka M. Arias, Keri Baum, Bettina C. Fries, Yohei Doi, Robin Patel, Barry N Kreiswirth, Robert A. Bonomo, Henry F. Chambers, Vance G. Fowler, César A. Arias, David van Duin, Lilian M. Abbo, Deverick J. Anderson, Rebekka M. Arias, César A. Arias, Keri Baum, Robert A. Bonomo, Henry F. Chambers, Liang Chen, Kean Lee Chew, Eric Cober, H. R. Cross, Partha Pratim De, Samit Desai, Sorabh Dhar, Valentina Di Castelnuovo, Lorena Díaz, An Q Dinh, Yohei Doi, Michelle Earley, Brandon Eilertson, Beth Evans, Scott Evans, Vance G. Fowler, Bettina C. Fries, Hainv Gao, Julia Garcia‐Diaz, Omai B. Garner, Kerryl E. Greenwood‐Quaintance, Blake Hanson, Erica Herc, Carol Hill, Jesse T. Jacob, Jianping Jiang, Robert C. Kalayjian, Souha S. Kanj, Keith S. Kaye, Angela Kim, Lauren Komarow, Barry N Kreiswirth, Courtney Lauterbach, Lanjuan Li, Zhengyin Liu, Claudia Manca, Kalisvar Marimuthu, Steven H. Marshall, Todd P McCarty, José M. Munita, Oon Tek Ng, Jose Millan Oñate Gutierrez, Karen Ordóñez, Robin Patel, David L. Paterson, Anton Y. Peleg, Jinnethe Reyes, Susan D. Rudin, Robert A. Salata, Soraya Salcedo, Michael J. Satlin, Suzannah M. Schmidt-Malan, Nares Smitasin, María Spencer ほか 14 名 - The Lancet Infectious Diseases 2021 被引用: 339

  6. Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study

    著者: David van Duin, César A. Arias, Lauren Komarow, Liang Chen, Blake Hanson, Gregory Weston, Eric Cober, Omai B. Garner, Jesse T. Jacob, Michael J. Satlin, Bettina C. Fries, Julia Garcia‐Diaz, Yohei Doi, Sorabh Dhar, Keith S. Kaye, Michelle Earley, Andrea M. Hujer, Kristine M. Hujer, Tatiana Domitrovic, William C. Shropshire, An Q Dinh, Claudia Manca, Courtney Luterbach, Minggui Wang, David L. Paterson, Ritu Banerjee, Robin Patel, Scott Evans, Carol Hill, Rebekka M. Arias, Henry F. Chambers, Vance G. Fowler, Barry N. Kreiswirth, Robert A. Bonomo - The Lancet Infectious Diseases 2020 被引用: 330

  7. Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae

    著者: David van Duin, Judith J. Lok, Michelle Earley, Eric Cober, Sandra S. Richter, Federico Pérez, Robert A. Salata, Robert C. Kalayjian, Richard Watkins, Yohei Doi, Keith S. Kaye, Vance G. Fowler, David L. Paterson, Robert A. Bonomo, Scott Evans, Antibacterial Resistance Leadership Group - Clinical Infectious Diseases 2017 被引用: 652

  8. RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections

    著者: J. Motsch, Cláudia Murta de Oliveira, V.P. Stus, İftihar Köksal, O. O. Lyulko, Helen W. Boucher, Keith S. Kaye, Thomas M. File, Michelle Brown, Ireen Khan, Jiejun Du, Hee‐Koung Joeng, Robert Tipping, Angela Aggrey, Katherine Young, Nicholas A. Kartsonis, Joan R. Butterton, Amanda Paschke - Clinical Infectious Diseases 2019 被引用: 404

  9. Health Care–Associated Bloodstream Infections in Adults: A Reason To Change the Accepted Definition of Community-Acquired Infections

    著者: N. Deborah Friedman, Keith S. Kaye, Jason E. Stout, Sarah A. McGarry, Sharon L. Trivette, Jane P. Briggs, Wanda Lamm, Connie Clark, Jennifer MacFarquhar, Aaron L. Walton, L. Barth Reller, Daniel J. Sexton - Annals of Internal Medicine 2002 被引用: 1,665

  10. Effect and Safety of Meropenem–Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial

    著者: Richard G. Wunderink, Evangelos J. Giamarellos‐Bourboulis, Galia Rahav, Amy J. Mathers, Matteo Bassetti, José A. Vázquez, Oliver A. Cornely, Joseph S. Solomkin, Tanaya Bhowmick, Jihad Bishara, George L. Daikos, Tim Felton, María José López Furst, E.J. Kwak, Francesco Menichetti, Ilana Oren, Elizabeth Alexander, David C. Griffith, Olga Lomovskaya, Jeffery S. Loutit, Shu Zhang, Michael N. Dudley, Keith S. Kaye - Infectious Diseases and Therapy 2018 被引用: 442

  11. Diabetes and Risk of Surgical Site Infection: A Systematic Review and Meta-analysis

    著者: Emily T. Martin, Keith S. Kaye, Caitlin Knott, Huong Nguyen, Maressa Santarossa, Richard B. Evans, Elizabeth A. Bertran, Linda A. Jaber - Infection Control and Hospital Epidemiology 2015 被引用: 648

  12. Colistin Monotherapy versus Combination Therapy for Carbapenem-Resistant Organisms

    著者: Keith S. Kaye, Dror Marchaim, Visanu Thamlikitkul, Yehuda Carmeli, Cheng‐Hsun Chiu, George L. Daikos, Sorabh Dhar, Emanuele Durante‐Mangoni, Achilleas Gikas, Αναστασία Κοτανίδου, Mical Paul, Emmanuelle Roilides, Michael J. Rybak, Michael Samarkos, Matthew Sims, Dora Tancheva, Sotirios Tsiodras, Daniel H. Kett, Gopi Patel, David P. Calfee, Leonard Leibovici, Laura E. Power, L. Silvia Muñoz-Price, Kurt Stevenson, Laura Susick, Katie Latack, Jolene Daniel, Christine C. Chiou, George Divine, Varduhi Ghazyaran, Jason M. Pogue - NEJM Evidence 2022 被引用: 143

  13. Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection

    著者: Keith S. Kaye, Tanaya Bhowmick, Symeon Metallidis, Susan C Bleasdale, Olexiy Sagan, V.P. Stus, José A. Vázquez, В. І. Зайцев, Mohamed Bidair, Erik Chorvat, Petru Octavian Drăgoescu, Elena Fedosiuk, Juan Pablo Horcajada, Claudia Murta, Y. V. Sarychev, Ventsislav Stoev, Elizabeth E. Morgan, Karen Fusaro, David C. Griffith, Olga Lomovskaya, Elizabeth Alexander, Jeffery S. Loutit, Michael N. Dudley, Evangelos J. Giamarellos‐Bourboulis - JAMA 2018 被引用: 306

  14. Strategies to prevent surgical site infections in acute-care hospitals: 2022 Update

    著者: Michael S. Calderwood, Deverick J. Anderson, Dale W. Bratzler, E. Patchen Dellinger, Sylvia Garcia‐Houchins, Lisa L. Maragakis, Ann‐Christine Nyquist, Kiran M. Perkins, Michael Anne Preas, Lisa Saiman, Joshua K. Schaffzin, Marin L. Schweizer, Deborah S. Yokoe, Keith S. Kaye - Infection Control and Hospital Epidemiology 2023 被引用: 257

  15. A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study)

    著者: Ivan Titov, Richard G. Wunderink, Antoine Roquilly, Daniel González, Aileen David-Wang, Helen W. Boucher, Keith S. Kaye, Maria C Losada, Jiejun Du, Robert Tipping, Matthew L. Rizk, Munjal Patel, Michelle Brown, Katherine Young, Nicholas A. Kartsonis, Joan R. Butterton, Amanda Paschke, Luke F. Chen - Clinical Infectious Diseases 2020 被引用: 225

  16. In critically ill patients, anti-anaerobic antibiotics increase risk of adverse clinical outcomes

    著者: Rishi Chanderraj, Jennifer M. Baker, Stephen G. Kay, Christopher A. Brown, Kevin J. Hinkle, Daniel J. Fergle, Roderick A. McDonald, Nicole R. Falkowski, Joseph D. Metcalf, Keith S. Kaye, Robert J. Woods, Hallie C. Prescott, Michael W. Sjoding, Robert P. Dickson - European Respiratory Journal 2022 被引用: 129

  17. Clinical Outcomes and Bacterial Characteristics of Carbapenem-resistant Acinetobacter baumannii Among Patients From Different Global Regions

    著者: Minggui Wang, Lizhao Ge, Liang Chen, Lauren Komarow, Blake Hanson, Jinnethe Reyes, Eric Cober, Thamer H. Alenazi, Zhiyong Zong, Qing Xie, Zhengyin Liu, Lanjuan Li, Yunsong Yu, Hainv Gao, Souha S. Kanj, Jairo Figueroa, Erica Herc, Ezequiel Córdova, Gregory Weston, Paul Anantharajah Tambyah, Julia Garcia‐Diaz, Keith S. Kaye, Sorabh Dhar, José M. Munita, Robert A. Salata, Samuel Vilchez, Martín E. Stryjewski, María Virginia Villegas, Alina Iovleva, Scott Evans, Keri Baum, Carol Hill, Barry N. Kreiswirth, Robin Patel, David L. Paterson, Cesar A Arias, Robert A. Bonomo, Henry F. Chambers, Vance G. Fowler, Michael J. Satlin, David van Duin, Yohei Doi, Multi-Drug Resistant Organism Network Investigators, Souha S. Kanj, Fujie Zhang, Judith J. Lok, Robert A. Salata, Martín E. Stryjewski, Valentina Di Castelnuovo, Jose Millan Oñate Gutierrez, Eric Cober, Susan Richter, Deverick J. Anderson, Beth Evans, Carol Hill, H. R. Cross, Keri Baum, Rebekka M. Arias, Vance G Fowler, Karen Ordóñez, Jesse T. Jacob, Linghua Li, Barry N Kreiswirth, Claudia Manca, Liang Chen, Samit Desai, Erica Herc, Ezequiel Córdova, María Luisa Rioseco, Samuel Vilchez, Marisa Sánchez, Sandra Valderrama, Jairo Figueroa, Cesar A Arias, An Q Dinh, Diane Panesso, Kirsten Rydell, Truc T. Tran, Fupin Hu, Jiachun Su, Jianping Jiang, Minggui Wang, Xiaogang Xu, Yang Yang, José M. Munita, María Spencer, Thamer H. Alenazi, Robert A. Bonomo, Steven H. Marshall, Susan D. Rudin, W. Charles Huskins, Kerry Greenwood-Quaintance, Robin Patel, Suzannah M. Schmidt-Malan, Sara Revolinski, Glenn Wortmann, Robert C. Kalayjian, Gregory Weston, Belinda Ostrowsky, Gopi Patel ほか 48 名 - Clinical Infectious Diseases 2023 被引用: 94

  18. Effect of Cefepime/Enmetazobactam vs Piperacillin/Tazobactam on Clinical Cure and Microbiological Eradication in Patients With Complicated Urinary Tract Infection or Acute Pyelonephritis

    著者: Keith S. Kaye, Adam Belley, Philip Barth, Omar Lahlou, Philipp Knechtle, Paola Motta, Patrick Vélicitat - JAMA 2022 被引用: 117

  19. Strategies to Prevent Surgical Site Infections in Acute Care Hospitals: 2014 Update

    著者: Deverick J. Anderson, Kelly Podgorny, Sandra I. Berríos-Torres, Dale W. Bratzler, E. Patchen Dellinger, Linda Greene, Ann-Christine Nyquist, Lisa Saiman, Deborah S. Yokoe, Lisa L. Maragakis, Keith S. Kaye - Infection Control and Hospital Epidemiology 2014 被引用: 1,205

  20. Ceftolozane/Tazobactam vs Polymyxin or Aminoglycoside-based Regimens for the Treatment of Drug-resistant Pseudomonas aeruginosa

    著者: Jason M. Pogue, Keith S. Kaye, Michael P. Veve, Twisha S Patel, Anthony T. Gerlach, Susan L. Davis, Laura Puzniak, T. M. File, Shannon Olson, Sorabh Dhar, Robert A. Bonomo, Federico Pérez - Clinical Infectious Diseases 2019 被引用: 205

  21. Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus

    著者: Roger L. Nation, Jian Li, Otto Cars, William Couet, Michael N. Dudley, Keith S. Kaye, Johan W. Mouton, David L. Paterson, Vincent H. Tam, Ursula Theuretzbacher, Brian T. Tsuji, John Turnidge - The Lancet Infectious Diseases 2014 被引用: 343

  22. Antimicrobial Resistance Trends in Urine Escherichia coli Isolates From Adult and Adolescent Females in the United States From 2011 to 2019: Rising ESBL Strains and Impact on Patient Management

    著者: Keith S. Kaye, Vikas Gupta, Aruni Mulgirigama, Ashish V. Joshi, Nicole E. Scangarella-Oman, Kalvin Yu, Gang Ye, Fanny S Mitrani-Gold - Clinical Infectious Diseases 2021 被引用: 135

  23. Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial

    著者: Michael S. Niederman, Jeff Alder, Matteo Bassetti, Francis Boateng, Bin Cao, K Corkery, Rajiv Dhand, Keith S. Kaye, Robert Lawatscheck, Patrick McLeroth, David P. Nicolau, Chen Wang, G. Christopher Wood, Richard G. Wunderink, Jean Chastre - The Lancet Infectious Diseases 2019 被引用: 131

  24. Current Epidemiology, Etiology, and Burden of Acute Skin Infections in the United States

    著者: Keith S. Kaye, Lindsay A Petty, Andrew F. Shorr, Marya D. Zilberberg - Clinical Infectious Diseases 2019 被引用: 176